Roche’s response to the COVID-19 pandemic

Roche is deeply committed to supporting India's COVID-19 testing need.


Our goal is to support the Indian healthcare system in its battle against COVID-19, by enabling access to quality diagnostic solutions at various stages of disease progression.

Narendra Varde

Managing Director, Roche Diagnostics India & Neighboring Markets

Detecting SARS-CoV-2 in currently infected patients with high sensitivity1

Laboratory tests


Molecular test (PCR)


The cobas® SARS-CoV-2 Test is a real-time RT-PCR test intended for the qualitative detection of nucleic acids from SARS-CoV-2 in nasal, nasopharyngeal, and oropharyngeal swab samples from patients. 

cobas® SARS-CoV-2 Test


Both tests can run on Roche’s fully automated cobas® 6800 and cobas® 8800 Systems.

cobas® 6800 System

cobas® 8800 System


FDA-Emergency Use Authorisation, CE-IVD

India CDSCO approval issued due to an emergency health situation in the public interest.


Detecting a patient’s immune response to SARS CoV-2 with high specificity2,3

Laboratory tests


Antibody test


Elecsys® Anti-SARS-CoV-2 is an immunoassay for the in vitro qualitative detection of antibodies (including IgG) to SARS-CoV-2 in human serum and plasma. The test is intended as an aid in the determination of the immune reaction to SARS-CoV-2.

Elecsys® Anti-SARS-CoV-2


Elecsys® Anti-SARS-CoV-2 S is an immunoassay for the in vitro quantitative determination of antibodies (including IgG) to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD) in human serum and plasma. The test is intended as an aid to assess the adaptive humoral immune response to the SARS‑CoV‑2 S protein.

Elecsys® Anti-SARS-CoV-2 S


The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.

cobas e 411

cobas e 601 module

cobas e 602 module

cobas e 801 analytical unit

When to use which
SARS‑CoV‑2 diagnostic test4


Reliable diagnostic tests targeting patients that are currently infected by the virus, as well as those that have an immune response against the virus, are valuable. However, it is important to understancd which tests are most suitable to use depending on their intended purpose.

icon of a person

Is my sickness COVID‑19?

Tests that detect the virus


  • RT-PCR 
icon of a person

How is my body's immune system reacting to the virus?

Tests that detect immune response and potential immunity*


  • Antibody tests

* Uncontested proof of protective immunity in persons with antibodies against SARS-CoV-2 is pending. Data presented here are based on current scientific understanding of the disease (Jan 2021)

An overview of SARS-CoV-2 diagnostic tests available


Watch this video which explains the different diagnostic tests available for SARS-CoV-2 and when they are most effectively used.




COVID-19: coronavirus disease 2019

RT-PCR: reverse transcription polymerase chain reaction

  1. cobas® SARS-CoV-2 Method sheet (v3 May 2020). 
  2. Elecsys® Anti-SARS-CoV-2 method sheet (v4, Dec, 2020). 
  3. Elecsys® Anti-SARS-CoV-2 S. method sheet (v1, Sep,2020).
  4. European Commision (2020). Guidelines on COVID-19 in vitro diagnostic tests and their performance (published 15 April 2020). Available from [Accessed Jan 2021]